Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium vs Salmeterol on Arterial Blood Gases in COPD
NCT00274534Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Dec 2000; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00274534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274534.